Sunil Healthcare Limited (SUNLOC) fundamentals
Sunil Healthcare Limited is a listed company, part of the Chemicals sector, listed on the NSE as SUNLOC (ISIN INE671C01016). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Sunil Healthcare Limited does
Sunil Healthcare Limited is an India-based company, which is engaged in manufacturing hard shell capsules. The Company manufactures empty hard gelatin, hydroxypropyl methylcellulose (HPMC) capsule shells and ayurvedic medicines. The Company offers various capsules, including BSE/TSE Free Capsules, Pearl Capsules, Liquid Fill Capsules, Stick Free Capsules, Flavored Capsules, SLS Free Capsules, Natural Color Capsules, Non-Azo Capsules and Preservative Free Capsules. Its hard gelatin capsule shells are available in nine sizes, such as 00, 0SEL, 0EL, 0,1,2,3, 4, 5. Pullulan Capsules are a type of vegetable capsule made from pullulan. The Vegetable Capsules are commonly used as an option for gelatin because of its vegetarian source and its physical appearance to gelatin. The Company offers empty gelatin capsules that are flavorless, unscented, and colorless, making them simple to consume. Its product range caters to the pharma and food supplement industries.
Valuation and market data
| Last close | ₹75.50 |
|---|---|
| Market capitalisation | ₹78 crore |
| Enterprise value | ₹110 crore |
| P/E (TTM) | 0.00 |
| Price to book | 1.16 |
| Price to sales (TTM) | 0.91 |
| Book value per share | ₹65.18 |
| Dividend yield | 0.00% |
| Sector | Chemicals |
| Industry | — |
| Listed since | Mon Aug 17 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹89 crore | ₹-7 crore | ₹-5 crore | 0.00 |
| Mar 2025 | ₹85 crore | ₹0 crore | ₹0 crore | 0.20 |
| Mar 2024 | ₹94 crore | ₹-3 crore | ₹-2 crore | -2.06 |
| Mar 2023 | ₹113 crore | ₹10 crore | ₹7 crore | 6.80 |
| Mar 2022 | ₹118 crore | ₹10 crore | ₹7 crore | 6.61 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 73.5% |
|---|---|
| Foreign institutions (FII) | 0.0% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.1% |
| Retail and others | 26.4% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.